"Le Centre Antoine Lacassagne est multi-sites, nous vous invitons à bien vérifier l’adresse de votre rdv."

During the past decade, Centre Antoine Lacassagne / Oncologie Médicale conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Antoine Lacassagne / Oncologie Médicale" are "Carcinoma, Squamous Cell of the Head and Neck" (1 trials), "Lymphoma" (1 trials), "Lymphoma, Mantle-Cell" (1 trials), "Mantle Cell Lymphoma" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Centre Antoine Lacassagne / Oncologie Médicale" in a lesser frequency.

Most popular intervention types in "Centre Antoine Lacassagne / Oncologie Médicale" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials), "Rituximab" (2 trials), "ASTX660" (1 trials), "Carboplatin" (1 trials) and "Chemotherapy (Induction Period)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Antoine Lacassagne / Oncologie Médicale" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centre Antoine Lacassagne / Oncologie Médicale". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centre Antoine Lacassagne / Oncologie Médicale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Antoine Lacassagne / Oncologie Médicale, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".